TIPE2 and non-small cell lung carcinoma: While considering the univariate analysis for survival data of 1144 NSCLC patients from TCGA datasets, it was observed that the increasing copiousness of genetic alterations of the TIPE2 was associated with decreased DFS/PFS of NSCLC patients (Figure 2A,B).